ADBIOTECH Co.,Ltd.

Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.

179530 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 강원도 춘천시 동내면 거두단지1길 39, 춘천시
Website:: http://www.adbiotech.com
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ADBIOTECH Co., Ltd. is a biotechnology company specializing in the research, development, manufacturing, and sale of next-generation immune antibodies. The company's core technology is based on Immunoglobulin Y (IgY), producing specific antibodies from eggs as alternatives to conventional vaccines and antibiotics. Its product portfolio serves diverse markets, including livestock, aquaculture, and human health, with commercialized products sold both domestically and internationally. ADBIOTECH is actively expanding its R&D pipeline to include human therapies, such as Helico IgY and Cholesterol IgY, and is entering the global companion animal market with its proprietary VHH (nanobody) technology. The company manages the entire value chain from research to production and sales, positioning itself as a leader in the IgY technology field.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for ADBIOTECH Co.,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size
2025-09-15 00:00	Pre-Annual General Meeting Information [기재정정]주주총회소집결의 (임시주주총회)	Korean	31.7 KB
2025-09-15 00:00	Pre-Annual General Meeting Information 주주총회소집공고	Korean	133.2 KB
2025-09-15 00:00	Proxy Solicitation & Information Statement 의결권대리행사권유참고서류	Korean	81.3 KB

Automate Your Workflow. Get a real-time feed of all ADBIOTECH Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ADBIOTECH Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Genome&Company Clinical-stage biopharma developing cancer therapies using microbiome, immune inhibitors, and ADCs.	South Korea	314130
Genomictree Inc. Develops molecular diagnostics using DNA methylation biomarkers for early cancer detection.	South Korea	228760
Genomtec S.A. Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.	Poland	GMT
GENOTECH CORP. A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.	South Korea	066830
Gentian Diagnostics ASA Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.	Norway	GENT
GI Innovation Inc. Develops fusion protein biologics for oncology, allergic, and metabolic diseases.	South Korea	358570
GlaxoSmithKline PLC A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.	United Kingdom	GSK
GL Pharm Tech Corp. Develops improved drugs and generics, and licenses proprietary drug formulation technologies.	South Korea	204840
GNI Group Ltd. Biopharma firm developing novel drugs for cancer and inflammatory diseases using genetics.	Japan	2160
Goodwill Pharma Plc Integrated pharma CDMO developing Rx/OTC meds, supplements & devices for CEE markets.	Hungary	GWPH